title: Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis.
authors.affiliation: Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, U.K.
authors.forename: A
authors.initials: A
authors.lastname: Bond
authors.forename: L
authors.initials: L
authors.lastname: Corlett
authors.forename: N
authors.initials: N
authors.lastname: Nagvekar
authors.forename: L
authors.initials: L
authors.lastname: Jacobson
authors.forename: N
authors.initials: N
authors.lastname: Pantic
authors.forename: D
authors.initials: D
authors.lastname: Beeson
authors.forename: M
authors.initials: M
authors.lastname: Nicolle
authors.forename: A
authors.initials: A
authors.lastname: Vincent
authors.forename: J
authors.initials: J
authors.lastname: Newsom-Davis
authors.forename: E
authors.initials: E
authors.lastname: Spack
authors.forename: N
authors.initials: N
authors.lastname: Willcox
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001324:Autoantigens / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009045:Motor Endplate / Q000276:immunology / Q000502:physiology; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy; D009157:Myasthenia Gravis / Q000276:immunology* / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D013945:Thymoma / Q000276:immunology; D013953:Thymus Neoplasms / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D001324:Autoantigens; D011948:Receptors, Antigen, T-Cell; D011950:Receptors, Cholinergic; D011994:Recombinant Proteins